Hit-and-run vaccine system that overcomes limited neoantigen epitopes for efficient broad antitumor response

H Chen, Z Huang, J Li, S Dong, Y Xu, S Ma, J Zhao… - Science Bulletin, 2024 - Elsevier
Neoantigen cancer vaccines have been envisioned as one of the most promising means for
cancer therapies. However, identifying neoantigens for tumor types with low tumor mutation …
被引用次数：3 相关文章

Hit-and-run vaccine system that overcomes limited neoantigen epitopes for efficient broad antitumor response

H Chen, Z Huang, J Li, S Dong, Y Xu, S Ma… - Science …, 2024 - pubmed.ncbi.nlm.nih.gov
Neoantigen cancer vaccines have been envisioned as one of the most promising means for
cancer therapies. However, identifying neoantigens for tumor types with low tumor mutation …

Hit-and-run vaccine system that overcomes limited neoantigen epitopes for efficient broad antitumor response.

H Chen, Z Huang, J Li, S Dong, Y Xu, S Ma, J Zhao… - Science …, 2024 - europepmc.org
Neoantigen cancer vaccines have been envisioned as one of the most promising means for
cancer therapies. However, identifying neoantigens for tumor types with low tumor mutation …

Hit-and-run vaccine system that overcomes limited neoantigen epitopes for efficient broad antitumor response

H Chen, Z Huang, J Li, S Dong, Y Xu, S Ma… - Science …, 2024 - ui.adsabs.harvard.edu
Neoantigen cancer vaccines have been envisioned as one of the most promising means for
cancer therapies. However, identifying neoantigens for tumor types with low tumor mutation …